BBlogFlow

Planning Inspectorate’s Business Plan for 2025-2026 published - GOV.UK

·Jul 24, 2025

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. GOV.UK

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

6 Million Barrels in Two Minutes Draws CFTC Scrutiny - Crude Oil Prices Today | OilPrice.com

Oil traders sold futures equivalent to at least 6 million barrels of crude in just two minutes on March 23, shortly before President Donald Trump backed away from threats to strike Iranian power plants. Now, the federal regulator overseeing those trades says it has been looking into the activity. Commodity Futures Trading Commission Chairman Michael Selig said Friday that the agency's enforcement division has been examining oil trading during the Iran war, including the unusual surge preceding Trump's announcement. "Our enforcement division has been looking at all these trades," Selig told Bloomberg Television. "We take this stuff very seriously. "The March 23 selling involved Brent and West Texas Intermediate futures. Trading volume during the two-minute window was more than 8.5 times the volume recorded during the same period over the preceding week, according to Bloomberg. The timing has raised questions about whether some traders had advance knowledge of Trump's plans. Oil markets have been particularly sensitive to presidential announcements since the Iran war began in February, with threats of military strikes and subsequent reversals capable of triggering sharp price swings.

Crude Oil Prices Today | OilPrice.com·

$120 Oil Is Almost Here, and Trump Has Few Good Options - Crude Oil Prices Today | OilPrice.com

Tom majored in International Business at Amsterdam’s Higher School of Economics and later completed an Executive MBA in Energy Transition at the University of Groningen.… Brent crude nears $120 as escalating Saudi-Houthi tensions fuel another weekly oil price rally, putting fresh pressure on Trump. Friday, October 23, 2026The slow creep of oil prices towards the $120 per barrel mark is a nightmarish scenario for US President Trump, even though there has been little fundamental change in the crude oil markets. A slight drop in freight rates and a ubiquitous flattening of backwardated curves lowered differentials of most grades globally, offsetting some of the pressures coming from higher crude benchmarks. Be that as it may, an escalating Saudi-Houthi conflict paved the way for another 4% weekly gain, with ICE Brent trading around $117 per barrel. First Russian Diesel Cargo Heads for New York. A non-sanctioned tanker, the Maltese-flagged Agioi Fanendes, left Russia’s Baltic Sea port of Primorsk with New York listed as its destination, marking the first diesel cargo under Trump’s deal with Moscow with final delivery expected on November 7.

Crude Oil Prices Today | OilPrice.com·

A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study - CBC

HealthA first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. Combined with an existing treatment, the vaccine helped reduce risk of melanoma returning by 42 per centLauran Neergaard · The Associated Press · Posted: Oct 23, 2026 11:10 AM EDT | Last Updated: 2 hours agoListen to this articleEstimated 5 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. After the results of a major study of Moderna and Merck's new mRNA cancer vaccine were leaked on Thursday, the companies released the full data ahead of the planned Saturday reveal. (LookerStudio/Shutterstock.)A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. The vaccine was custom-brewed for each patient to match their tumor.

CBC·